ScholarIQanswers from OpenAlex & ORCID
John de Groot
ResearcherPublications, citations & collaboration network
John de Groot is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does John de Groot have?
ScholarIQindexed works
John de Groot has 617 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does John de Groot have?
ScholarIQcitation count
John de Groot has 20,224 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of John de Groot?
ScholarIQh-index
John de Groot has an h-index of 71 in OpenAlex.
What is the i10-index of John de Groot?
ScholarIQi10-index
John de Groot has an i10-index of 173 in OpenAlex.
What is the ORCID of John de Groot?
ScholarIQorcid
The ORCID for John de Groot is on the source record.
What is the OpenAlex record for John de Groot?
ScholarIQopenalex
The OpenAlex for John de Groot is on the source record.
What are the most-cited papers on John de Groot?
ScholarIQmost cited works
Neoadjuvant anti-PD-1 immunotherapy promotes a survival benefit with intratumoral and systemic immune responses in recurrent glioblastoma
Timothy F. Cloughesy, Aaron Mochizuki, Joey Orpilla, Willy Hugo, Alex Lee, Tom B. Davidson, Anthony Wang, Benjamin M. Ellingson, Julie Rytlewski, Catherine Sanders, Eric S. Kawaguchi, Lin Du, Gang Li, William H. Yong, Sarah Gaffey, Adam L. Cohen, Ingo K. Mellinghoff, Eudocia Q. Lee, David A. Reardon, Barbara O’Brien, Nicholas Butowski, Phioanh L. Nghiemphu, Jennifer Clarke, Isabel Arrillaga‐Romany, Howard Colman, Thomas Kaley, John de Groot, Linda M. Liau, Patrick Y. Wen, Robert M. Prins
Single-cell analyses reveal increased intratumoral heterogeneity after the onset of therapy resistance in small-cell lung cancer
C. Allison Stewart, Carl M. Gay, Yuanxin Xi, Santhosh Sivajothi, V. Sivakamasundari, Junya Fujimoto, Mohan Bolisetty, Patrice M. Hartsfield, Veerakumar Balasubramaniyan, Milind D. Chalishazar, César A. Moran, Neda Kalhor, John Stewart, Hai T. Tran, Stephen G. Swisher, Jack A. Roth, Jianjun Zhang, John de Groot, Bonnie S. Glisson, Trudy G. Oliver, John V. Heymach, Ignacio I. Wistuba, Paul Robson, Jing Wang, Lauren A. Byers
Randomized Phase II and Biomarker Study of Pembrolizumab plus Bevacizumab versus Pembrolizumab Alone for Patients with Recurrent Glioblastoma
Lakshmi Nayak, Annette M. Molinaro, Katherine B. Peters, Jennifer Clarke, Justin T. Jordan, John de Groot, Leia Nghiemphu, Thomas Kaley, Howard Colman, Christine McCluskey, Sarah Gaffey, Timothy R. Smith, David J. Coté, Mariano Severgnini, Jennifer H. Yearley, Qing Zhao, Wendy M. Blumenschein, Dan G. Duda, Alona Muzikansky, Rakesh K. Jain, Patrick Y. Wen, David A. Reardon